Latest News and Press Releases
Want to stay updated on the latest news?
-
Phase 3 wet AMD trials, LUGANO and LUCIA, remain on track with topline data expected beginning mid-2026 –Phase 3 DME clinical trials, COMO and CAPRI, rapidly advancing with over one-third of patients...
-
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and...
-
Prism Investigator is the first fully autonomous investigations platform among Gartner-tracked DCGA vendors, designed to accelerate compliance and legal investigations.The source-agnostic AI platform...
-
Luxembourg, May 05, 2026 (GLOBE NEWSWIRE) -- OCEANICA LUX, a private limited liability company (société à responsabilité limitée) incorporated under the laws of Grand Duchy of Luxembourg, with its...
-
Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust (“Flagship” or the...
-
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or the “Company”) announced its operating and financial results for the first quarter ended...
-
Improves Q1 Combined Ratio to 96.0%,Earns $1.05 per diluted share; Repurchases $5 million of ordinary shares GRAND CAYMAN, Cayman Islands, May 05, 2026 (GLOBE NEWSWIRE) -- Greenlight Capital Re,...
-
GAAP Net Income of $168 million, or $1.18 per diluted shareAdjusted Operating Income of $172 million, or $1.21 per diluted shareReturn on Equity of 12.5% and Adjusted Operating Return on Equity of...
-
Robbins Geller is investigating whether PicS N.V. and certain of its top executives made materially false and/or misleading statements to investors.
-
Trevi Therapeutics to host conference call and webcast today, May 5, on 1Q 2026 financial results and business updates